You are on page 1of 14

Clinical Case Studies

Behavioral Activation of a Breast Cancer Patient With Coexistent Major Depression

and Generalized Anxiety Disorder
Maria E. A. Armento and Derek R. Hopko
Clinical Case Studies 2009 8: 25
DOI: 10.1177/1534650108327474

The online version of this article can be found at:

Published by:

Additional services and information for Clinical Case Studies can be found at:

Email Alerts:





>> Version of Record - Jan 12, 2009

What is This?

Downloaded from by Andreea Nicoleta Nicolae on October 12, 2011

Clinical Case Studies
Volume 8 Number 1
February 2009 25-37
© 2009 Sage Publications
Behavioral Activation of a Breast
hosted at

Cancer Patient With Coexistent

Major Depression and Generalized

Anxiety Disorder
Maria E. A. Armento
Derek R. Hopko
University of Tennessee

Recently developed behavioral activation interventions have shown promise in effectively

treating depression through increasing value-based activity levels that elicit response-
contingent reinforcement. This case study highlights the implementation of behavioral
activation to a breast cancer patient with major depression and generalized anxiety disorder,
applied within the context of a medical center oncology clinic. Following an eight-session
behavioral activation protocol, the patient demonstrated notable decreases in self-reported
depressive and anxious symptoms and an overall increase in quality of life and medical
functioning. These treatment gains were maintained through 6-month follow-up. Consistent
with an accumulating literature, these data support behavioral activation as an effective and
parsimonious intervention for individuals with depression and concurrent medical problems
such as breast cancer.

Keywords: breast cancer; behavioral activation; depression; anxiety

1 Theoretical and Research Basis

The American Cancer Society estimates that approximately 180,000 cases of invasive
breast cancer and 62,000 cases of (ductal or lobular) carcinoma in situ will be diagnosed
among U.S. women in the upcoming year. Breast cancer is the most frequently diagnosed
cancer type among women (American Cancer Society, 2007; Dausch et al., 2004) and the
prevalence rate of clinical depression in breast cancer patients may approximate 18%-57%
(Badger, Sergrin, Dorros, Meek, & Lopez, 2007; Dausch et al., 2004; Monti, Mago, &
Kunkel, 2005). Researchers have investigated the short- and long-term effects that psycho-
logical distress (i.e., depression and anxiety) may have on women with breast cancer.
Emotional distress may be associated with increased difficulty coping with side effects of
cancer treatment, more health complaints, more significant physical and functional impair-
ment if cancer recurs following treatment, and possibly a higher risk of mortality depending
on the stage of breast cancer and onset of depression (Badger et al., 2007; Hjerl et al., 2003;

Authors’ Note: Please address correspondence to Derek R. Hopko, 307 University of Tennessee–Knoxville,
Department of Psychology, Room 301D, Austin Peay Building, Knoxville, TN 37996-0900; e-mail:


Downloaded from by Andreea Nicoleta Nicolae on October 12, 2011

26 Clinical Case Studies

Monti et al., 2005). The stress associated with being diagnosed and treated for breast cancer
can be immense, significantly increasing depression and anxiety, reducing quality of life, and
decreasing engagement in rewarding activities and participation in social behaviors (Badger
et al., 2007; Dausch et al., 2004; Deshields, Tibbs, Fan, & Taylor, 2006; Hopko & Lejuez,
2007; Kissane et al., 2004; Monti et al., 2005; Wong-Kim & Bloom, 2005).
Psychological interventions for breast cancer patients have included pharmacological
and/or cognitive-behavioral stress management techniques conducted in individual, group,
or family formats (Andersen, 1992; Antoni et al., 2001; Baum & Andersen, 2001; Kissane
et al., 2004; McGregor et al., 2004; Ronson & Razavi, 2000; Speca, Carlson, Goodey, &
Angen, 2000; Trisjsburg, van Knippenberg, & Rijpma, 1992). Interventions differ in goals
and strategies depending on presenting problems, stage of disease, and whether chemother-
apy or radiotherapy is provided. Specific psychosocial interventions have included psy-
choeducational strategies, supportive psychotherapy, cognitive restructuring, relaxation
training, problem-solving and social skills training, biofeedback, and hypnosis (Antoni et al.,
2001; Golden & Gersh, 1990; Moorey, Greer, Bliss, & Law, 1998; Nezu, Nezu, Houts,
Friedman, & Faddis, 1999). However, well-designed treatment outcome research assessing
the relative efficacy of these approaches has been minimal, and studies examining their
efficacy among cancer patients with well-diagnosed depression is greatly lacking (Hopko
et al., 2008; Spiegel & Giese-Davis, 2003). Indeed, it is clear that depression in breast can-
cer patients may be significantly underdiagnosed and undertreated (Badger, Braden,
Mishel, & Longman, 2004; McQuaid et al., 1999; Spiegel & Giese-Davis, 2003).
A recent revitalization of behavioral interventions for depression (Hopko & Lejuez, 2007;
Lejuez, Hopko, & Hopko, 2002; Martell, Addis, & Jacobson, 2001) has focused on behav-
ioral activation approaches that show promise in effectively treating depression through sys-
tematically increasing value-based activity levels that elicit increased response-contingent
reinforcement (Dimidjian et al., 2006; Hollon, 2001; Hopko et al., 2005, 2008; Hopko,
Lejuez, Ruggiero, & Eifert, 2003b; Jacobson, Dobson, Truax, & Addis, 1996). Behavioral
theories of depression posit that decreased response-contingent positive reinforcement
(RCPR) or punishment of nondepressive behaviors and/or reinforcement of depressive
behaviors result in increased depressive affect (Ferster, 1973; Lewinsohn, 1974). Behavioral
activation for depressed cancer patients (Hopko & Lejuez, 2007) has several features that not
only make it a viable intervention for a medical care setting (e.g., uncomplicated, time effi-
cient) but also has aspects that may be particularly appealing for cancer patients. First, the
time efficiency not only better meets the demands of a medical care environment but also the
needs of cancer patients who may already be physically and emotionally overwhelmed by
their cancer treatment. Second, behavioral activation is specifically designed to encourage
healthy nondepressive behavior by way of guided activity leading to an increase in “control”
over one’s life (and overt behavior), an attribute that may be useful in restoring the loss of
control often experienced by cancer patients (Twillman & Manetto, 1998). Third, behavioral
activation addresses components deemed essential in the effective treatment of breast can-
cer patients with mental health problems that include social and family support, emotional
expression, the reordering of life priorities, and issues of symptom control (Spiegel, 1999).
The structure of the treatment also is compatible with the structured psychoeducational
intervention model for cancer patients whereby health education, stress management, and
behavioral coping skills (and avoidance reduction) are targeted (Fawzy, Fawzy, & Canada,

Downloaded from by Andreea Nicoleta Nicolae on October 12, 2011

Armento, Hopko / Behavioral Activation 27

2001). Finally, behavioral activation allows for a flexible treatment that can be tailored to the
unique needs of patients taking into consideration differences in patient demographics, treat-
ment goals, and coexistent psychological and medical symptoms. This case study represents
an exploration of the effectiveness of behavioral activation in treating a patient with breast
cancer and coexistent major depression and generalized anxiety disorder.

2 Case Presentation
The patient was a 58-year-old married White female with 4 years of college education
and a career as a nurse. At the commencement of therapy, she was unemployed due to knee
surgery and was not actively seeking employment.

3 Presenting Complaints
Upon entering therapy, the patient reported she was experiencing depressive and anxious
symptoms. Among her depressive symptoms was a depressed mood that had been present
for 2 years, starting with her breast cancer diagnosis. She also reported significant loss of
energy and impaired concentration along with moderate feelings of worthlessness, hyper-
somnia, and a decrease in appetite. Generalized anxiety symptoms also were reported that
included persistent and uncontrollable worry about a number of life areas such as work,
family, finances, social issues, and personal health. Psychosomatic symptoms of anxiety
included significant difficulty concentrating, becoming easily fatigued, moderate muscle
tension, sleep difficulties, and mild irritability. The patient reported the onset of anxiety
symptoms about a year prior to entering therapy, precipitated by knee surgery that affected
her ability to work. The patient reported utilizing avoidant behaviors to try and reduce her
anxious thoughts (e.g., thought suppression, watching television, sleeping excessively).
These avoidant behaviors became linked to her depressed mood, which further inhibited her
from engaging in previously rewarding overt behaviors. Another complication to this
patient’s situation were two significant Axis III problems (i.e., a breast cancer diagnosis 2
years prior to therapy and knee surgery 1 year prior) that required her to reevaluate how
current behavioral patterns and life goals might be changed as a function of these health
issues. These precipitators increased anxiety about her future. Although some previously
emitted positive behaviors had been discontinued due to avoidance and decreased motiva-
tion associated with depressed affect, decreased engagement in other previously reinforced
behaviors (e.g., work activities, health behaviors) were more directly related to physical

4 History
As stated, the patient’s depressive and anxiety symptoms had been present for approxi-
mately 2 years and 1 year, respectively. The primary events proximal to the onset of these
symptoms were the patient’s diagnosis of breast cancer 2 years earlier and difficulties

Downloaded from by Andreea Nicoleta Nicolae on October 12, 2011

28 Clinical Case Studies

recovering from knee surgery about a year earlier. The patient was diagnosed with Stage 2
breast cancer (left laterality) with a tumor size of 2.1 cm. She had positive estrogen and
progesterone receptor status and was negative for the HER-2/NEU gene. Subsequent to the
cancer diagnosis, the patient had a lumpectomy followed by radiation and chemotherapy.
The patient reported previous episodes of depression that included two psychiatric inpa-
tient hospitalizations during the 1980s and one hospitalization for alcohol addiction (1989)
that appeared to function as a maladaptive strategy to cope with memories of an abusive
childhood. The patient reported that her father frequently was physically abusive during her
youth and that she often experienced migraine headaches and depressive affect which she
associated with this abuse. The patient indicated that vivid memories of her childhood
abuse began to manifest during the 1980s and that alcohol abuse seemed to be the most
effective strategy by which to inhibit these memories. She initially engaged in psychother-
apy in the late 1980s and remained in therapy for about 5 years. The patient reported great
improvement following psychotherapy that focused on using cognitive-behavioral therapy
to develop coping strategies to minimize the frequency and intensity of aversive thoughts
and emotions related to early childhood abuse.

5 Assessment
The patient presented to the interview as well groomed and attentive. Her speech rate
was noticeably slowed and her tone and volume were quiet. The patient was oriented on all
spheres. Mild psychomotor agitation was evident and was consistent with the patient’s
mood that was described as depressed and somewhat anxious. Affect was congruent with
mood. There was no evidence of perceptual distortions or any indication of suicidal
ideation. Thought process, as exhibited by verbal behavior, was slowed but logical and the
patient appeared to be of above average intellect. The patient had adequate insight about
her psychological symptoms.
The patient was administered a semistructured interview (The Anxiety Disorder Interview
Schedule for DSM-IV; Brown, DiNardo, & Barlow, 1994) that revealed coexistent diagnoses
of major depression and generalized anxiety. Her multiaxial diagnosis was as follows:

Axis I: 296.32 Major depressive disorder, recurrent

300.02 Generalized anxiety Disorder
Axis II: Diagnosis deferred
Axis III: 239.9 Breast cancer
959.9 Knee injury/replacement
Axis IV: Employment issues
Axis V: GAF = 60

Prior to therapy, the patient completed several self-report assessment measures:

The Beck Depression Inventory (BDI-II; Beck, Steer, & Brown, 1996) consists of 21 items, each
rated on a 4-point Likert-type scale. There has been strong support for the reliability and validity
of the measure with depressed younger (Nezu, Ronan, Meadows, & McClure, 2000) and older
adults (Stanley, Novy, Bourland, Beck, & Averill, 2001).

Downloaded from by Andreea Nicoleta Nicolae on October 12, 2011

Armento, Hopko / Behavioral Activation 29

The Center for Epidemiological Studies of Depression Scale (CES-D; Radloff, 1977) is a 20-item
self-report questionnaire of depressive symptoms that has good psychometric properties (Radloff,
1977) and has been shown to modestly relate to a diagnosis of clinical depression (Myers &
Weissman, 1980).
The Environmental Reward Observation Scale (EROS; Armento & Hopko, 2007) is a 10-item
measure (responded to on a 1- to 4-point Likert-type Scale) that assesses RCPR or the experience
of increased behavior and positive affect as a consequence of rewarding environmental experi-
ences. Good psychometric properties (i.e., internal consistency, test-retest reliability, convergent
validity) have been demonstrated for the measure (Armento & Hopko, 2007).
The Beck Anxiety Inventory (BAI; Beck & Steer, 1990) is a 21-item questionnaire designed to dis-
tinguish cognitive and somatic symptoms of anxiety from those of depression. Good psychome-
tric properties have been demonstrated for the measure among community, medical, and
psychiatric outpatient samples (Morin et al., 1999; Osman, Kopper, Barrios, Osman, & Wade,
1997; Steer, Willman, Kay, & Beck, 1994; Wetherell & Areán, 1997).
The Quality of Life Inventory (QOLI; Frisch, 1994) is a 16-item instrument that evaluates quality
of life across various domains of functioning (e.g., health, relationships, money). Ratings of
importance and satisfaction are made for each domain, with an overall score calculated by aver-
aging satisfaction ratings for all domains assigned nonzero importance ratings. Total scores range
from –6 to +6. The QOLI appears to be a reliable and valid measure of life satisfaction (Frisch,
The Medical Outcomes Study Short Form (SF-36; Ware & Sherbourne, 1992) is a well-known
survey that assesses health and functional status. The instrument includes eight subscales: phys-
ical functioning (PF), role disability due to physical problems (RP), bodily pain (BP), health per-
ceptions (HP), vitality (V), social functioning (SF), role disability due to emotional problems
(RE), and general mental health (GH).
The Multidimensional Scale of Perceived Social Support (MSPSS; Zimet, Dahlem, Zimet, &
Farley, 1988) is a 12-item scale that assesses adequacy of social support from family, friends, and
significant others. The instrument has adequate psychometric properties in clinical and nonclini-
cal samples of adults (Stanley, Beck, & Zebb, 1998; Zimet et al., 1988).

In addition to these self-report measures, the clinician also completed the Hamilton
Rating Scale for Depression (HRSD; Hamilton, 1960), a 24-item semistructured interview
designed to measure symptom severity in patients with depression (Hamilton, 1960). The
instrument is the most widely used and accepted outcome measure for evaluating depres-
sion and has become the standard outcome measure in clinical trials (Kobak & Reynolds,
Pretreatment assessment occurred 1 week prior to beginning the behavioral activation
protocol. The patient’s scores on pretreatment measures were as follows: BDI-II = 25
(moderate depression; Beck et al., 1996); CES-D = 46; EROS = 21; BAI = 15 (moderate
anxiety; Beck & Steer, 1993); QOLI = –3; SF-36, PF = 30, RP = 0, SF = 12.5, HP = 48,
RE = 0, V = 30, GH = 50, BP = 31; MSPSS = 22; and HRSD = 25.

6 Case Conceptualization
The case formulation was based on a behavioral model of depression grounded in func-
tional analytic theorems (Ferster, 1973; Hopko & Lejuez, 2007). Beginning with Skinner

Downloaded from by Andreea Nicoleta Nicolae on October 12, 2011

30 Clinical Case Studies

(1953), who theorized that depression was associated with an interruption of a repertoire of
healthy behavior that had previously been positively reinforced in the social environment,
a number of researchers have suggested that overall decreases in response-contingent rein-
forcement for nondepressive behavior are a causal factor in eliciting depressive affect
(Ferster, 1973; Hopko et al., 2003b; Lewinsohn, 1974; Martell et al., 2001). A functional
analytic view proposes that a combination of reinforcement for depressed behavior and a
lack of reinforcement or even punishment of more healthy alternative behaviors lead to
depressed affect and a pattern of depressed, unhealthy behavior (Ferster 1973; Hopko et al.,
2003b). In the case of this patient, antecedents to depressive affect were her diagnosis and
treatment of breast cancer as well as her difficulty regaining mobility after knee surgery.
These events had a significant impact on the patient’s overt behaviors, access to environ-
mental reinforcement, self-identity, and anticipated life goals. Previously rewarded behav-
iors such as working at her job and spending time hiking or exercising had become less
enjoyable and sometimes physically impossible. This led to a decrease in positive rein-
forcement (and increased punishment when pain became debilitating) for activities she had
previously found pleasurable, causing her to begin a cycle of avoidance and less healthy
behaviors (e.g., passivity, oversleeping). Although the patient found herself spending less
time being active and taking part in more avoidant, passive, and unhealthy behaviors, she
recognized that this behavioral routine was worsening her negative affect. At the same time,
she was mildly rewarded by these maladaptive behaviors in the context of controlling her
symptoms of pain, as well as generalized anxiety, noting that she could effectively avoid
anxious thoughts through such behaviors as watching television and oversleeping.
Importantly, this patient had previously been a very physically active person, and the inabil-
ity to behave in a manner consistent with this value and accomplish the same goals she had
previously set for herself further worsened her negative affect.

7 Course of Treatment and Assessment of Progress

Based on this case conceptualization, the patient was treated using the behavioral acti-
vation manualized protocol for cancer patients (Hopko & Lejuez, 2007). In addition to the
core activation component outlined below, the protocol included psychoeducation about
cancer and its relation to emotional experiences and behavioral changes (during the first
session). In addition, the protocol included three journal assignments designed to increase
exposure and acceptance of issues surrounding cancer (i.e., writing about “being diagnosed
with cancer”, “living with cancer,” and “writing a letter to a friend who had been diagnosed
with cancer”). These exercises were assigned in each of the first three sessions.
The behavioral activation treatment was based on an “acceptance versus change” model
(Hayes, Strosahl, & Wilson, 1999) in which the patient was presented with the rationale that
some things in life are controllable and changeable, whereas there are other experiences that
we cannot change and thus must be met with acceptance (e.g., being diagnosed with cancer).
The same logic is applied to negative emotional states that are perceived as very difficult to
directly target. Instead, the primary mechanism for improving affect is to target what we have
more power to control and change, namely, overt behavior. Once modified, these changes in

Downloaded from by Andreea Nicoleta Nicolae on October 12, 2011

Armento, Hopko / Behavioral Activation 31

overt behavior bring about different (and more rewarding) environmental consequences that
positively affect mood, energy level, motivation, and thinking patterns. Through this process,
the patient gradually experiences increased response-contingent reinforcement that facilitates
relief from depression and anxiety symptoms.
The behavioral activation intervention was carried out over eight, 1-hr sessions, con-
ducted weekly. The patient had been prescribed 500 mg of Wellbutrin (qd) during treatment
and had been stabilized on this medication for 8 weeks prior to initiating psychotherapy.
Initial sessions included building rapport with the patient, explanation of the treatment
rationale, working toward creating a healthier environment, identifying important life areas
and establishing life goals, beginning to confront cancer through behavioral exposure
accomplished through journal assignment, and beginning to establish measurable and
observable target activities consistent with the patient’s life-goal assessment. During the
first session, the patient was asked to take an exercise home to examine already occurring
daily activities through use of a daily diary. This assignment provided a baseline measure-
ment of the patient’s activities that allowed the patient to become more aware of the qual-
ity and quantity of her activities while also providing a baseline measure for following
progress of treatment. This exercise also provided an opportunity to gather ideas for poten-
tial activities to target. During the second session, focus shifted to identifying the patient’s
values and goals within various life areas including family, social, and intimate relation-
ships, as well as education, employment, hobbies or recreation, volunteer work, physical
and psychological health, and spirituality. An activity hierarchy was developed from this
list during the third session, and 13 activities were identified and rated from easiest to most
difficult for the patient to accomplish. These activities included some new activities (e.g.,
socializing with women from her support group outside of meeting times), some previously
rewarding activities that she was no longer engaging in or wanted to increase the time she
did engage in them (e.g., exercise, time with husband), and activities that were designed to
accomplish long-term goals (e.g., activities leading toward reestablishing a professional
career). Using a master activity log and behavioral checkout to monitor progress, the
patient progressively moved through the hierarchy of activities over sessions from easiest
to most difficult to accomplish. Patient and therapist together discussed what the final goal
duration and frequency would be and this was recorded on the master activity log that was
kept by the therapist (a sample master activity log is presented in Table 1). The patient and
therapist also discussed weekly goal assignments which were recorded on a behavioral
checkout form that the patient took home, completed, and brought back to the next session.
At the beginning of each session, the behavioral checkout was discussed and new goals for
the coming week were set based on the successes or difficulties associated with the previous
week’s goals. As indicated on the master activity log in Table 1, the patient exhibited very
good compliance. At posttreatment, compliance was assessed by calculating the proportion
of behaviors assigned versus those completed. The patient’s compliance score was 94.2%.
Exposure and relaxation exercises were incorporated into the behavioral hierarchy to
work through some of the patient’s generalized anxiety symptoms, particularly targeting
her health-related concerns with regard to her cancer diagnosis. As described earlier, expo-
sure exercises involved journal entries pertaining to experiences of being diagnosed,
treated, and living with cancer culminating with the completion of a written exercise

Downloaded from by Andreea Nicoleta Nicolae on October 12, 2011

32 Clinical Case Studies

Table 1
Sample of Patient’s Master Activity Log
Ideal Goal Week 4 Week 5 Week 6 Week 7a

Goal Goal Goal Goal

Activity No. Time No. Time Do No. Time Do No. Time Do # Time Do

Exercise 7 30 m 3 20 5 3 20 3 3 20 4 3 20 3
Time talking 7 UF 1 UF 3 3 UF 3 1 UF 3
with husband
Activity with 7 UF 3 UF 6 3 UF 5
Support group 5 1h 3 UF 5 3 UF 4 3 UF 3 3 UF 3
Attend church 1 UF 1 UF 1 1 UF 1 1 UF 1
Sitter elderly 5 8h 1 UF 1 6-12h 5
Visit Chatanooga 1/m UF 1 UF 2 UF 1
Hiking or 2 UF UF 2 1 UF 1 1 UF 1
walking with
Social activity 2 UF UF 2
with women
from SG
Granddaughter 1/m UF 1 UF 1
spend night

Note: UF = Until Finished

designed to help a friend cope with being diagnosed with cancer. Through each of these
journal assignments, the patient was able to approach her thoughts and emotions about her
health and her diagnosis. She became progressively more skilled at articulating her emo-
tional and cognitive experiences and reported that these exercises were cathartic and help-
ful for “moving through” her cancer experiences, coming to a greater level of acceptance
about her diagnosis, and being more comfortable with approaching (rather than avoiding)
difficult memories and stressful experiences in general. Regular exercise was also a stan-
dard assignment incorporated into the patient’s master activity log in an effort to further
develop stress management skills. The patient reported feeling less anxious and less
depressed as she became more committed to a regular exercise routine.
Consistent with this verbal report, the posttreatment assessment revealed notable
decreases in depressive and anxious symptoms as well as improved quality of life and psy-
chosocial functioning. At posttreatment, the patient’s scores on measures were as follows:
BDI-II = 0; CES-D = 0; EROS = 32; BAI = 0; QOLI = 3; SF36, PF = 70, RP = 25, SF =
75, HP = 76, RE = 100, V = 70, GH = 60, BP = 51; MSPSS = 12; HRSD = 2. Patient sat-
isfaction with behavioral activation was assessed with the Client Satisfaction Questionnaire
(CSQ; Larsen, Attkisson, Hargreaves, & Nguyen, 1979), with data indicating strong patient
satisfaction (CSQ = 29.0/32).

Downloaded from by Andreea Nicoleta Nicolae on October 12, 2011

Armento, Hopko / Behavioral Activation 33

8 Complicating Factors
The most prominent complicating factor for this patient involved unresolved grief sur-
rounding her cancer diagnosis, which effectively was addressed via completion of written
exposure exercises and subsequent therapist–patient verbal exploration. Another compli-
cating factor was the patient’s physical limitations associated with knee surgery approxi-
mately a year prior to therapy. During her treatment, exercise and health activities were
targeted along with coordinated rehabilitation of her knee provided by a physical therapist.
Consequently, the patient had increased mobility, less pain, and increased energy, greatly
contributing to her ability to successfully obtain RCPR.

9 Managed Care Considerations (if any)

Data have supported the utility of behavioral activation strategies among depressed
patients in the context of a community mental health center (Lejuez, Hopko, LePage,
Hopko, & McNeil, 2001), an inpatient psychiatric facility (Hopko, Lejuez, LePage, Hopko,
& McNeil, 2003a), as a treatment within medical care settings for depressed cancer patients
(Hopko et al., 2005, 2008) and in the context of rigorous randomized controlled trials
(Dimidjian et al., 2006; Jacobson et al., 1996). The flexible, uncomplicated, and time-effi-
cient nature of behavioral activation likely makes it a practical intervention within primary
care settings where resources and time may be limited.

10 Follow-Up
Assessment at 3- and 6-month follow-up revealed maintenance of gains in terms of
reduced depression and anxiety symptoms as well as the improved quality of life and psy-
chosocial improvements documented at posttreatment.
At 3 months follow-up, the patient’s scores on all measures were as follows: BDI-II = 0;
CES-D = 3; EROS = 40; BAI = 0; QOLI = 4; SF36, PF = 95, RP = 100, SF = 100, HP =
100, RE = 100, V = 90, GH = 90, BP = 94; MSPSS = 12; and HRSD = 0. Patient satisfac-
tion with treatment actually increased at 3-month follow-up (CSQ = 32/32) perhaps sug-
gesting that patient realization of how behavioral activation positively affects mood and
thought process increases over time.
At 6 months follow-up, the patient’s scores on all measures were as follows: BDI-II = 1;
CES-D = 1; EROS = 37; BAI = 0; QOLI = 4; SF36, PF = 90, RP = 100, SF = 100, HP =
92, RE = 100, V = 70, GH = 85, BP = 94; MSPSS = 14; and HRSD = 0. Patient satisfac-
tion with treatment continued to be strong (CSQ = 32/32).

11 Treatment Implications of the Case

Perhaps the most important implication of this case resides in the effective use of a
behavioral activation protocol to treat a patient presenting with both a major medical

Downloaded from by Andreea Nicoleta Nicolae on October 12, 2011

34 Clinical Case Studies

problem and coexistent psychiatric problems. Given the prevalence of breast cancer and
the high rate of depression exhibited by women with breast cancer, the initial successes
of behavioral activation interventions administered within medical care settings is excit-
ing because it provides a treatment option for women who historically have been under-
treated for their depression. In addition, this study demonstrates that the uncomplicated,
time-effective, flexible, and ideographic nature of behavioral activation may be adequate
to observe clinically significant patient change across a breadth of outcome variables.
Finally, given the positive treatment outcome and corresponding reductions in anxiety,
which we largely ascribe to increasing approach-oriented behaviors (and reducing avoid-
ance) to facilitate environmental reinforcement, there is some support for a unified model
of emotional disorders. More specifically, it seems plausible that behavioral activation may
effectively treat coexistent depressive and anxiety disorders that are theoretically linked on
the basis of a core problem with avoidance behavior (Barlow, Allen, & Choate, 2004).

12 Recommendations to Clinicians and Students

A significant proportion of patients with depression and anxiety who present to primary
care are misdiagnosed, undiagnosed, and untreated (McQuaid et al., 1999; Schuyler, 2000).
Those who are diagnosed and treated often report only moderate to low quality of care for
depression (Wells, Schoenbaum, Unutzer, Lagomasino, & Rubenstein, 1999). Accordingly,
there is a pressing need for quality improvement with an emphasis on treatment efficacy
and cost-effectiveness for depression treatments within medical care settings. The use of a
behavioral activation protocol may be helpful for clinicians and students looking to imple-
ment a time-efficient treatment that can be individualized to patient’s experiencing signifi-
cant and coexistent Axis I and III diagnoses while also respecting the infrastructure and
operating procedures of medical care settings.

American Cancer Society. (2007). Cancer facts and figures for 2007. Available from
Andersen, B. L. (1992). Psychological interventions for cancer patients to enhance the quality of life. Journal
of Consulting and Clinical Psychology, 60, 552-568.
Antoni, M. H., Lehman, J. M., Kilbourn, K. M., Boyers, A. E., Culver, J. L., Alferi, S. M., et al. (2001).
Cognitive-behavioral stress management intervention decreases the prevalence of depression and enhances
benefit finding among women under treatment for early-stage breast cancer. Health Psychology, 20, 20-32.
Armento, M. E. A. & Hopko, D. R. (2007). The Development and Validation of the Environmental Reward
Observation Scale (EROS). Behavior Therapy, 38, 107-119.
Badger, T., Braden, C. J., Mishel, M. H., & Longman, A. (2004). Depression burden, psychological adjustment, and
quality of life in women with breast cancer: Patterns over time. Research in Nursing and Health, 27, 19-28.
Badger, T., Segrin, C., Dorros, S. M., Meek, P., & Lopez, A. M. (2007). Depression and anxiety in women with
breast cancer and their partners. Nursing Research, 56(1), 44-53.
Baum, A., & Andersen, B. L. (2001). Psychosocial interventions for cancer. Washington, DC: American
Psychological Association.
Beck, A. T., & Steer, R. A. (1990). Beck Anxiety Inventory: Manual. San Antonio, TX: Psychological

Downloaded from by Andreea Nicoleta Nicolae on October 12, 2011

Armento, Hopko / Behavioral Activation 35

Beck, A. T., & Steer, R. A. (1993). Beck Anxiety Inventory Manual. San Antonio, TX: Psychological
Corporation, Harcourt Brace.
Beck, A. T., Steer, R. A. & Brown, G. K. (1996). Manual for Beck Depression Inventory-II. San Antonio, TX:
Psychological Corporation
Brown, T. A., Di Nardo, P., & Barlow, D. H. (1994). Anxiety Disorders Interview Schedule for DSM-IV. San
Antonio, TX: Psychological Corporation.
Dausch, B. M., Compas, B. E., Beckjord, E., Luecken, L., Anderson-Hanley, C., Sherman, M., et al. (2004).
Rates and correlates of DSM-IV diagnoses in women newly diagnosed with breast cancer. Journal of
Clinical Psychology in Medical Settings, 11, 159-169.
Deshields, T., Tibbs, T., Fan, M., & Taylor, M. (2006). Differences In patterns of depression after treatment for
breast cancer. Psycho-Oncology, 15, 398-406.
Dimidjian, S., Hollon, S., Dobson, K., Schmaling, K., Kohlenberg, B., Addis, M. E., et al. (2006). Randomized
trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of
adults with major depression. Journal of Consulting and Clinical Psychology, 74, 658-670.
Fawzy, F. I., Fawzy, N. W., & Canada, A. L. (2001). Psychoeducational intervention programs for patients with
cancer. In A. Baum & B. L. Andersen (Eds.), Psychosocial interventions for cancer (pp.235-267).
Washington, DC: American Psychological Association.
Ferster, C. B. (1973). A functional analysis of depression. American Psychologist, 28, 857-870.
Frisch, M. B. (1994). Manual and Treatment Guide for the Quality of Life Inventory. Minneapolis, MN:
National Computer Systems.
Frisch, M. B. (1999). Quality of life assessment/intervention and the Quality of Life Inventory (QOLI). In
M. E. Maruish (Ed.), The use of psychological testing for treatment planning and outcome assessment
(2nd ed., pp. 1277-1331). Mahwah, NJ: Erlbaum.
Golden, W. L., & Gersh, W. D. (1990). Cognitive-behavioral therapy in the treatment of cancer patients. Journal
of Rational Emotive and Cognitive Behavior Therapy, 8, 41-51.
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56-61.
Hayes, S. C., Strosahl, K. D., & Wilson, K. G. (1999). Acceptance and commitment therapy: An experiential
approach to behavior change. New York: Guilford Press.
Hjerl, K., Anderson, E. W., Keiding, N., Mouridsen, H. T., Mortensen, P. B., & Jorgensen, T. (2003). Depression
as a prognostic for breast cancer mortality. Psychosomatics: Journal of Consultation and Liaison Psychiatry,
44, 24-30.
Hollon, S. D. (2001). Behavioral activation treatment for depression: A commentary. Clinical Psychology:
Science and Practice, 8, 271-274.
Hopko, D. R., Bell, J. L, Armento, M. E. A., Hunt, M. K, & Lejuez, C. W. (2005). Behavior therapy for depressed
cancer patients in primary care. Psychotherapy: Theory, Research, Practice, Training, 42, 236-243.
Hopko, D. R., Bell, J. L., Armento, M. E. A., Robertson, S. M. C., Mullane, C., Wolf, N., et al. (2008).
Cognitive-Behavior Therapy for Depressed Cancer Patients in a Medical Care Setting. Behavior Therapy, 9,
Hopko, D. R., & Lejuez, C. W. (2007). A Cancer Patient’s Guide to Overcoming Depression and Anxiety:
Getting Through Treatment and Getting Back to Your Life. Oakland, CA: New Harbinger.
Hopko, D. R., Lejuez, C. W., LePage, J., Hopko, S. D., & McNeil, D. W. (2003a). A brief behavioral activation
treatment for depression: A randomized trial within an inpatient psychiatric hospital. Behavior Modification,
27, 458-469.
Hopko, D. R., Lejuez, C. W., & Ruggiero, K. J., & Eifert, G. H. (2003b). Contemporary behavioral activation
treatments for depression: Procedures, principles, progress. Clinical Psychology Review, 23, 699-717.
Jacobson, N. S., Dobson, K. S., Truax, P. A., & Addis, M. E. (1996). A component analysis of cognitive-
behavioral treatment for depression. Journal of Consulting and Clinical Psychology, 64, 295-304.
Kissane, D. W., Grabsch, B., Love, A., Clarke, D. M., Bloch, B., & Smith, G. C. (2004). Psychiatric disorder
in women with early stage and advanced breast cancer: A comparative analysis. Australian and New Zealand
Journal of Psychiatry, 38, 320-326.
Kobak, K. A., & Reynolds, W. M. (1999). Hamilton Depression Inventory. In M. E. Maruish (Ed.), The Use of
Psychological Testing for Treatment Planning and Outcomes Assessment (2nd ed., pp. 935-969). Mahwah,
NJ: Lawrence Erlbaum.

Downloaded from by Andreea Nicoleta Nicolae on October 12, 2011

36 Clinical Case Studies

Larsen, D. L., Attkisson, C. C., Hargreaves, W. A., & Nguyen, T. D. (1979). Assessment of client/patient satis-
faction: Development of a general scale. Evaluation and Program Planning, 2, 197-207.
Lejuez, C. W., Hopko, D. R., & Hopko, S. D. (2002). The brief behavioral activation treatment for depression
(BATD): A Comprehensive patient guide. Boston: Pearson Custom.
Lejuez, C. W., Hopko, D. R., LePage, J., Hopko, S. D., & McNeil, D. W. (2001). A brief behavioral activation
treatment for depression. Cognitive and Behavioral Practice, 8, 164-175.
Lewinsohn, P. M. (1974). A behavioral approach to depression. In R. M. Friedman and M. M. Katz (Eds). The
psychology of depression: Contemporary theory and research (pp. 157-185). New York: Wiley.
Martell, C. R., Addis, M. E., & Jacobson, N. S. (2001). Depression in context: Strategies for guided action. New
York: Norton.
McGregor, B. A., Antoni, M. H., Boyers, A., Alferi, S. M., Blomberg, B. B., & Carver, C. S. (2004). Cognitive-
behavioral stress management increases benefit finding and immune function among women with early-
stage breast cancer. Journal of Psychosomatic Research, 56, 1-8.
McQuaid, J. R., Stein, M. B., Laffaye, C., & McCahill, M. E. (1999). Depression in a primary care clinic: The
prevalence and impact of an unrecognized disorder. Journal of Affective Disorders, 55, 1-10.
Monti, D. A., Mago, R., & Kunkel, E. J. S. (2005). Depression, cognition, and anxiety among postmenopausal
women with breast cancer. Practical Geriatrics, 56, 1353-1355.
Moorey, S., Greer, S., Bliss, J., & Law, M. (1998). A comparison of adjuvant psychological therapy and sup-
portive counseling in patients with cancer. Psycho-Oncology, 7, 218-228.
Morin, C. M., Landreville, P., Colecchi, C., McDonald, K., Stone, J., & Ling, W. (1999). The Beck Anxiety
Inventory: Psychometric properties with older adults. Journal of Clinical Geropsychology, 5, 19-29.
Myers, J. K., & Weissman, M. M. (1980). Use of a self-report symptom scale to detect major depression in a
community sample. American Journal of Psychiatry, 137, 1081-1084.
Nezu, A. M., Nezu, C. M., Houts, P. S., Friedman, S. H., & Faddis, S. (1999). Relevance of problem-solving
therapy to psychosocial oncology. Journal of Psychosocial Oncology, 16, 5-26.
Nezu, A. M., Ronan, G. F., Meadows, E. A., & McClure, K. S. (2000). Practitioner’s guide to empirically based
measures of depression. New York: Kluwer Academic/Plenum.
Osman, A., Kopper, B. A., Barrios, F. X., Osman, J. R., & Wade, T. (1997). The Beck Anxiety Inventory:
Reexamination of factor structure and psychometric properties. Journal of Clinical Psychology, 53, 7-14.
Radloff, L. (1977). The CES-D scale: A self-report depression scale for research in the general population.
Applied Psychological Measurement, 1, 385-401.
Ronson, A., & Razavi, D. (2000). Affective and anxiety disorders in patients with cancer: Optimal management.
In K. J. Palmer (Ed.), Depression associated with medical illness (pp. 113-128). Hong Kong, Peoples
Republic of China: Adis International.
Schuyler, D. (2000). Depression comes in many disguises to the providers of primary care: Recognition and
management. Journal of South Carolina Medical Association, 96, 267-275.
Skinner, B. F. (1953). Science and human behavior. New York: Free Press.
Speca, M., Carlson, L. E., Goodey, E., & Angen, M. (2000). A randomized, wait-list controlled clinical trial:
The effect of a mindfulness meditation-based stress reduction program on mood and symptoms of stress in
cancer outpatients. Psychosomatic Medicine, 62, 613-622.
Spiegel, D. (1999). Psychotherapeutic intervention with the medically ill. In D. S. Janowky (Ed.),
Psychotherapy: Indications and outcomes (pp. 277-300). Washington, DC: American Psychiatric Press.
Spiegel, D., & Giese-Davis, J. (2003). Depression and cancer: Mechanisms and disease progression. Biological
Psychiatry, 54, 269-282.
Stanley, M. A., Beck, J. G., & Zebb, B. J. (1998). Psychometric properties of the MSPSS in older adults. Aging
and Mental Health, 2, 186-193.
Stanley, M. A., Novy, D. M., Bourland, S. L., Beck, J. G., & Averill, P. M. (2001). Assessing older adults with
generalized anxiety: A replication and extension. Behaviour Research and Therapy, 39, 221-235.
Steer, R. A., Willman, M., Kay, P. A., & Beck, A. T. (1994). Differentiating elderly medical and psychiatric out-
patients with the Beck Anxiety Inventory. Assessment, 1, 345-351.
Trisjsburg, R. W., van Knippenberg, F. C. E., & Rijpma, S. E. (1992). Effects of psychological treatment on can-
cer patients: A critical review. Psychosomatic Medicine, 54, 489-517.

Downloaded from by Andreea Nicoleta Nicolae on October 12, 2011

Armento, Hopko / Behavioral Activation 37

Twillman, R. K., & Manetto, C. (1998). Concurrent psychotherapy and pharmacotherapy in the treatment of
depression and anxiety in cancer patients. Psycho-Oncology, 7, 285-290.
Ware, J. E., & Sherbourne, C. D. (1992). The MOS 36-Item Short-Form Health Survey (SF-36): I. Conceptual
framework and item selection. Medical Care, 30, 473-483.
Wells, K. B., Schoenbaum, M., Unutzer, J., Lagomasino, I. T., & Rubenstein, L. V. (1999).Quality of care for
primary care patients with depression in managed care. Archives of Family Medicine, 8, 529-536.
Wetherell, J. L., & Areán, P. A. (1997). Psychometric evaluation of the Beck Anxiety Inventory with older med-
ical patients. Psychological Assessment, 9, 136-144.
Wong-Kim, E. C., & Bloom, J. R. (2005). Depression experienced by young women newly diagnosed with
breast cancer. Psycho-Oncology, 14, 564-573.
Zimet, G. D., Dahlem, N. W., Zimet, S. G., & Farley, G. K. (1988). The Multidimensional Scale of Perceived
Social Support. Journal of Personality Assessment, 17, 37-49.

Maria E. A. Armento, MA, is a graduate student in clinical psychology at the University of Tennessee. Her
research interests involve innovations in behavioral assessment and exploring the efficacy of cognitive-behavioral
treatments for depression.

Derek Hopko, PhD, is an Associate Professor of clinical psychology and Associate Department Head of psy-
chology at the University of Tennessee. His research program focuses on health psychology and emotional dis-
orders, with primary interests in psychosocial treatment outcome research for depressed cancer patients.

Downloaded from by Andreea Nicoleta Nicolae on October 12, 2011